Cargando…
Reduction of SIRT1 epigenetically upregulates NALP1 expression and contributes to neuropathic pain induced by chemotherapeutic drug bortezomib
BACKGROUND: Bortezomib is a frequently used chemotherapeutic drug for the treatment of multiple myeloma and other nonsolid malignancies. Accumulating evidence has demonstrated that bortezomib-induced persistent pain serves as the most frequent reason for treatment discontinuation. METHODS: The von F...
Autores principales: | Chen, Kun, Fan, Jing, Luo, Zhao-Fan, Yang, Ying, Xin, Wen-Jun, Liu, Cui-Cui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6195754/ https://www.ncbi.nlm.nih.gov/pubmed/30342528 http://dx.doi.org/10.1186/s12974-018-1327-x |
Ejemplares similares
-
GATA3-dependent epigenetic upregulation of CCL21 is involved in the development of neuropathic pain induced by bortezomib
por: Zheng, Yaochao, et al.
Publicado: (2019) -
Inhibition of microRNA-155 Reduces Neuropathic Pain During Chemotherapeutic Bortezomib via Engagement of Neuroinflammation
por: Duan, Zongsheng, et al.
Publicado: (2020) -
Dysregulation of sphingolipid metabolism contributes to bortezomib-induced neuropathic pain
por: Stockstill, Katherine, et al.
Publicado: (2018) -
Spinal SIRT1 Activation Attenuates Neuropathic Pain in Mice
por: Shao, Haijun, et al.
Publicado: (2014) -
Curcumin ameliorates neuropathic pain by down-regulating spinal IL-1β via suppressing astroglial NALP1 inflammasome and JAK2-STAT3 signalling
por: Liu, Shenbin, et al.
Publicado: (2016)